Multiresistant gram-negative bacteria: A bacterial challenge of the twenty-first century;Multiresistente gramnegative Bakterien: Problemkeime des 21. Jahrhunderts

Medizinische Klinik - Intensivmedizin und Notfallmedizin

Volumn 108, Issue 2, 2013, Pages 107-112

  Schroppel K ^a,b   Riessen, R ^b  

^a Medhyg Institut für Medizinhygiene   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Antibiotic stewardship; Antibiotics; Infection control; Multiresistant pathogens; Standard hygiene

Indexed keywords

ARTICLE; CRITICALLY ILL PATIENT; GRAM NEGATIVE BACTERIUM; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION RISK; INTENSIVE CARE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; VANCOMYCIN RESISTANT ENTEROCOCCUS; ANTIBIOTIC RESISTANCE; CROSS INFECTION; DISINFECTION; DRUG EFFECTS; ENTEROCOCCUS; EVIDENCE BASED MEDICINE; GENETICS; GENOTYPE; GERMANY; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HYGIENE; INTENSIVE CARE UNIT; MICROBIAL SENSITIVITY TEST; OPPORTUNISTIC INFECTIONS; PHENOTYPE; STANDARDS; STAPHYLOCOCCAL INFECTIONS;

ANTIINFECTIVE AGENT;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DISINFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROCOCCUS; EVIDENCE-BASED MEDICINE; GENOTYPE; GERMANY; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; HYGIENE; INTENSIVE CARE UNITS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; OPPORTUNISTIC INFECTIONS; PHENOTYPE; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN RESISTANCE;

EID: 84879593074     PISSN: 21936218     EISSN: 21936226     Source Type: Journal    
DOI: 10.1007/s00063-012-0160-8     Document Type: Article

References (36)

1. Tübbicke A, Hübner C, Hübner NL et al (2012) Cost comparison of MRSA screening and management - a decision tree analysis. BMC Health Serv Res 12: 438.
2. Moise PA, Amodio Groton M, Rashid M et al (2012) Clinical outcomes of Daptomycin with and without concomitant beta-lactams in patients with Staphylococcus aureus bacteremia and mild to moderate renal impairment: a multicenter evaluation. Antimicrob Agents Chemother 57: 1192-2000.
3. Docobo-Pérez F, López-Rojas R, Domínguez-Herrera J et al (2012) Efficacy of linezolid versus a pharmacodynamically optimized vancomycin therapy in an experimental pneumonia model caused by methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 67(8): 1961-1967.
4. Ammerlaan HSM, Harbath S, Buiting AGM et al (2012) Secular trends in nosocomial bloodstream infections: antibiotic-resistant bacteria increase the total burden of infection. Clin Infect Dis 56: 798-805.
5. Mutters NT, Frank U (2013) Sources of systematic errors in the epidemiology of vancomycin-resistant enterococci. Infection [Epub ahead of print].
6. Armand-Lefèvre L, Angebault C, Barbier F et al (2013) Emergence of Imipenem-resistant Gram-negative bacilli in intestinal flora of intensive care patients. Antimicrob Agents Chemother 567(3): 1488-1495.
7. Ho J, Tambyah PA, Paterson DL (2010) Multiresistant Gram-negative infections: a global perspective. Curr Opin Infect Dis 23(6): 546-553.
8. Jain S, Khety Z (2012) Changing antimicrobial resistance pattern of isolates from an ICU over a 2 year period. J Assoc Physicians India 60: 27-28, 33.
9. Ku K et al (2012) Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem-resistant Enterobacteriaceae infections. Am J Infect Control 40(10): 983-987.
10. Layer F et al (2012) Current data and trends on methicillin-resistant Staphylococcus aureus (MRSA). Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 55(11-12): 1377-1386.
11. Wulf MW et al (2012) Infection and colonization with methicillin resistant Staphylococcus aureus ST398 versus other MRSA in an area with a high density of pig farms. Eur J Clin Microbiol Infect Dis 31(1): 61-65.
12. Cornaglia G et al (1999) Appearance of IMP-1 metallo-beta-lactamase in Europe. Lancet 353(9156): 899-900.
13. Endo S et al (2012) IMP-1-producing carbapenem-resistant Acinetobacter ursingii from Japan. J Antimicrob Chemother 67(10): 2533-2534.
14. Liu EM, Pegg KM, Oelschlaeger P (2012) The sequence-activity relationship between metallo-beta-lactamases IMP-1, IMP-6, and IMP-25 suggests an evolutionary adaptation to meropenem exposure. Antimicrob Agents Chemother 56(12): 6403-6406.
15. Mammina C et al (2012) Ongoing spread of colistin-resistant Klebsiella pneumoniae in different wards of an acute general hospital, Italy, June to December 2011. Euro Surveill 17(33).
16. Robert-Koch-Institut (2012) Hygienemaßnahmen bei Infektionen oder Besiedlung mit multiresistenten gramnegativen Stabchen. Empfehlung der Kommission für Krankenhaushygiene und Infektionspravention (KRINKO) beim Robert Koch-Institut (RKI). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 55(10): 1311-1354.
17. Singh K et al (2012) Rectal screening for Klebsiella pneumoniae carbapenemases: comparison of real-time PCR and culture using two selective screening agar plates. J Clin Microbiol 50(8): 2596-2600.
18. Boll EJ et al (2012) Novel screening assay for in vivo selection of Klebsiella pneumoniae genes promoting gastrointestinal colonisation. BMC Microbiol 12: 201.
19. Lolans K et al (2010) Direct ertapenem disk screening method for identification of KPC-producing Klebsiella pneumoniae and Escherichia coli in surveillance swab specimens. J Clin Microbiol 48(3): 836-841.
20. Su PA et al (2010) Screening extended-spectrum beta-lactamase production in Enterobacter cloacae and Serratia marcescens using antibiogram-based methods. J Microbiol Immunol Infect 43(1): 26-34.
21. Vahdani M et al (2012) Phenotypic screening of extended-spectrum ss-lactamase and metallo-ss-lactamase in multidrug-resistant Pseudomonas aeruginosa from infected burns. Ann Burns Fire Disasters 25(2): 78-81.
22. Lin SP et al (2012) Phenotypic detection and polymerase chain reaction screening of extended-spectrum beta-lactamases produced by Pseudomonas aeruginosa isolates. J Microbiol Immunol Infect 45(3): 200-207.
23. Wang L et al (2011) Construction of an effective screening system for detection of Pseudomonas aeruginosa quorum sensing inhibitors and its application in bioautographic thin-layer chromatography. Biotechnol Lett 33(7): 1381-1387.
24. Apisarnthanarak A, Warren DK (2012) Screening for Carbapenem-Resistant Acinetobacter baumannii colonization sites: an implication for combination of horizontal and vertical approaches. Clin Infect Dis 56(7): 1057-1059.
25. Lee BY et al (2011) Economic value of Acinetobacter baumannii screening in the intensive care unit. Clin Microbiol Infect 17(11): 1691-1697.
26. Willmann M, Marschal M, Hölzl F et al (2013) Time series analysis as a tool to predict the impact of antimicrobial restriction in antibiotic stewardship programs using the example of multidrug-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother [Epub ahead of print].
27. Jump RL et al (2012) Effective antimicrobial stewardship in a long-term care facility through an infectious disease consultation service: keeping a LID on antibiotic use. Infect Control Hosp Epidemiol 33(12): 1185-1192.
28. Jacob JT, Gaynes RP (2010) Emerging trends in antibiotic use in US hospitals: quality, quantification and stewardship. Expert Rev Anti Infect Ther 8(8): 893-902.
29. Lesprit P, Brun-Buisson C (2008) Hospital antibiotic stewardship. Curr Opin Infect Dis 21(4): 344-349.
30. Furuya EY et al (2011) Challenges of applying the SHEA/HICPAC metrics for multidrug-resistant organisms to a real-world setting. Infect Control Hosp Epidemiol 32(4): 323-332.
31. (o A) (2009) Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep 58(10): 256-260.
32. Cohen AL et al (2008) Recommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA/HICPAC Position paper. Infection Control Hospital Epidemiol 29(10): 901-913.
33. Hilty M et al (2012) Transmission dynamics of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the tertiary care hospital and the household setting. Clin Infect Dis 55(7): 967-975.
34. Tschudin-Sutter S et al (2012) Rate of transmission of extended-spectrum Beta-lactamase-producing enterobacteriaceae without contact isolation. Clin Infect Dis 55(11): 1505-1511.
35. Pollack LA, Gould CV, Srinivasan A (2013) If not now, when? Seizing the moment for antibiotic stewardship. Infect Control Hosp Epidemiol 34(2): 117-118.
36. Riedel S (2012) Procalcitonin and antibiotic therapy: can we improve antimicrobial stewardship in the intensive care setting? Crit Care Med 40(8): 2499-2500.